Study guide
26.2 Positron Emission Tomography (PET/CT) & Unsealed Radiation Source Safety
Philippine Radiologic Technologists Licensure Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Subject 1, Chapter 1: Physics of Radiology & X-Ray Production
1.1 Atomic Structure, Electromagnetic Spectrum & X-Ray Production Mechanisms 1.2 X-Ray Tube Components, Target Interactions & Emission Spectrum 1.3 Photon Interactions with Matter: Photoelectric, Compton, Coherent & Pair Production
2 Subject 1, Chapter 2: Radiographic Equipment & Circuitry
2.1 High-Voltage Generators, Transformers & Rectification Circuits 2.2 Automatic Exposure Control (AEC), Beam Restriction & Quality Control 2.3 Tube Rating Charts, Extending Tube Life, Mechanical Malfunction & Preventive Maintenance
3 Subject 1, Chapter 3: Radiobiology & Cellular Response
3.1 Radiation Interaction with Tissue, Direct/Indirect Action & LET/RBE 3.2 Law of Bergonie & Tribondeau, Deterministic vs. Stochastic Effects 3.3 Dose-Response Relationships, Embryo and Fetal Effects & Acute Radiation Syndrome
4 Subject 1, Chapter 4: Radiation Protection & Dose Limits
4.1 ALARA Principles, Structural Shielding & Dose Limits 4.2 Personnel Dosimetry & Patient Dose Reduction Techniques 4.3 Dose Calculation Problems: Time, Distance, Shielding & Structural Barrier Design
5 Subject 1, Chapter 5: Imaging Informatics & Quality Assurance
5.1 PACS Architecture, DICOM Standards & HL7 Integration 5.2 Quality Assurance & Quality Control Protocols in Diagnostic Radiography 5.3 Radiology Workflow, RIS/HIS Integration, Teleradiology & Informatics Quality Assurance
6 Subject 2, Chapter 6: Film-Screen Radiography & Sensitometry
6.1 Film Emulsion, Latent Image Formation & Darkroom Chemistry 6.2 Sensitometric Curve (H&D Curve), Film Speed & Contrast Characteristics 6.3 Radiographic Film Analysis: Processing Faults, Handling Artifacts & Corrective Measures
7 Subject 2, Chapter 7: Technical Factors & Radiographic Quality
7.1 Density/Brightness, Contrast, Spatial Resolution & Distortion Controls 7.2 Exposure Math: Inverse Square Law, 15% Rule & Grid Conversion Factors 7.3 Technique Compensation: Age, Pathology, Cast and Orthopaedic Devices, Screen Speed & Beam Restriction
8 Subject 2, Chapter 8: Computed Radiography (CR)
8.1 Photostimulable Phosphor (PSP) Plates & CR Reader Mechanics 8.2 Image Processing, CR Artifacts & Erasure Protocols
9 Subject 2, Chapter 9: Digital Radiography (DR)
9.1 Flat-Panel Detectors: Direct vs. Indirect Conversion & TFT Arrays 9.2 Detective Quantum Efficiency (DQE), Modulation Transfer Function (MTF) & Dynamic Range
10 Subject 2, Chapter 10: Exposure Indicators & Image Evaluation
10.1 Exposure Indicators (S-Number, EI, DI), Windowing & Look-Up Tables (LUT) 10.2 Image Critique Checklist, Artifact Identification & Quality Control Standards 10.3 Image Display & Hard-Copy Output: Monitor Classification, DICOM GSDF, Dry vs Wet Laser Imaging
11 Subject 3, Chapter 11: Chest, Abdomen & Routine Positioning Concepts
11.1 Anatomical Terminology, Body Planes & Chest Radiography (PA, Lateral, Decubitus) 11.2 Abdominal Radiography: Acute Abdomen Series & Erect/Supine Protocols 11.3 Radiologic Surface Anatomy, Body Habitus & Sectional Body Cuts
12 Subject 3, Chapter 12: Upper & Lower Extremities & Girdles
12.1 Upper Limb & Shoulder Girdle Positioning (Hand, Wrist, Forearm, Elbow, Humerus, Shoulder) 12.2 Lower Limb & Pelvic Girdle Positioning (Foot, Ankle, Leg, Knee, Femur, Pelvis, Hip)
13 Subject 3, Chapter 13: Spine & Bony Thorax
13.1 Cervical, Thoracic & Lumbar Spine Radiography & Trauma Adaptations 13.2 Sacrum, Coccyx, Sacroiliac Joints & Bony Thorax (Ribs & Sternum)
14 Subject 3, Chapter 14: Cranium, Facial Bones & Paranasal Sinuses
14.1 Skull Positioning: Towne, Caldwell, Lateral & SMV Projections 14.2 Facial Bones, Orbits, Zygomatic Arches & Paranasal Sinuses
15 Subject 3, Chapter 15: Contrast Media Studies & Special Procedures
15.1 Gastrointestinal Contrast Procedures (Esophagram, UGI, Small Bowel, Barium Enema) 15.2 Genitourinary, Biliary & Special Fluoroscopic Studies (IVU, Cystography, ERCP, Myelography) 15.3 Reproductive System Studies: Hysterosalpingography, Pelvimetry & Male Reproductive Procedures 15.4 Nasopharyngography, Sialography & Fistulography / Sinus Tract Visualization
16 Subject 4, Chapter 16: Human Anatomy, Physiology & Pathology Integration
16.1 Body System Anatomy & Systemic Physiology Overview for Radiographers 16.2 Radiologic Pathology: Image Manifestations of Neoplastic, Inflammatory & Traumatic Conditions
17 Subject 4, Chapter 17: Patient Assessment, Communication & Informed Consent
17.1 Professional Communication, History Taking & Patient Rights 17.2 Informed Consent, Medical Documentation & Patient Transfer Safety
18 Subject 4, Chapter 18: Infection Control & Vital Signs Monitoring
18.1 Standard Precautions, Asepsis, Sterilization & Isolation Protocols 18.2 Measurement & Assessment of Vital Signs (BP, Pulse, Respiration, Temperature)
19 Subject 4, Chapter 19: Emergency Care & Aseptic Venipuncture
19.1 Basic Life Support (BLS), CPR Concepts & Emergency Response in Radiology 19.2 Aseptic Venipuncture Technique, IV Maintenance & Extravasation Care
20 Subject 4, Chapter 20: Professional Ethics, Jurisprudence & RA 7431
20.1 Republic Act No. 7431 (Radiologic Technology Act of 1992) & Board Rules 20.2 Code of Professional Ethics, Legal Liabilities, Malpractice & Negligence 20.3 Bioethical Principles in Practice, Professional Virtues & Interprofessional Relationships
21 Subject 5, Chapter 21: Diagnostic Ultrasonography
21.1 Ultrasound Physics, Transducer Construction & Doppler Principles 21.2 Acoustic Artifacts, Clinical Applications & Safety (TI/MI) 21.3 Clinical Ultrasound Examinations: Indications, Patient Preparation, Scanning Protocols & Transducer Selection
22 Subject 5, Chapter 22: Computed Tomography (CT)
22.1 CT Physics, Gantry Components, Detectors & Helical/Multislice Acquisition 22.2 Hounsfield Units, Windowing, CT Artifacts & Radiation Dose (CTDI/DLP)
23 Subject 5, Chapter 23: Magnetic Resonance Imaging (MRI)
23.1 MRI Physics, Nuclear Spin, T1/T2 Relaxation & Pulse Sequences 23.2 MRI Safety (Zones I-IV, SAR, Metallic Implants) & Common Artifacts 23.3 MRI Examination Protocols, Patient Preparation, Gadolinium Contrast & Sectional MRI Anatomy
24 Subject 5, Chapter 24: Interventional Radiology & Vascular Imaging
24.1 Vascular Access, Seldinger Technique & Digital Subtraction Angiography (DSA) 24.2 Interventional Procedures (Embolization, Angioplasty, Stenting) & C-Arm Radiation Safety 24.3 Interventional Patient Management: Contrast Selection, Pre-Procedure Workup & Post-Procedure Care
25 Subject 5, Chapter 25: Contrast Media Pharmacology & Adverse Reactions
25.1 Classification of Contrast Agents: Osmolality, Viscosity & Iodine Concentration 25.2 Adverse Contrast Reactions (Mild, Moderate, Severe) & Emergency Treatment Protocols 25.3 General Pharmacologic Principles: Pharmacokinetics, Pharmacodynamics, Drug Categories & the Rights of Drug Safety
26 Subject 5, Chapter 26: Nuclear Medicine & Molecular Imaging
26.1 Radioisotopes, Radiopharmaceuticals & Gamma Camera / SPECT Operation 26.2 Positron Emission Tomography (PET/CT) & Unsealed Radiation Source Safety
27 Subject 5, Chapter 27: Radiation Therapy & Radiation Oncology
27.1 Principles of Radiation Oncology, Linear Accelerators & Treatment Planning 27.2 Teletherapy vs. Brachytherapy, Patient Immobilization & Side Effect Management 27.3 Isodose Planning, Treatment Delivery Methods & Radiobiologic Principles in Radiation Therapy
28 Mammography & Dental Radiography
28.1 Mammography: Equipment, CC and MLO Positioning, Compression & Breast Pathology 28.2 Dental Radiography: Paralleling and Bisecting Techniques, Bitewing, Occlusal, Panoramic & Cephalometric
29 Medical Terminology for Radiologic Technology
29.1 Medical Word Building: Root Words, Combining Forms, Prefixes & Suffixes 29.2 Medical Terms in General Medicine, Abbreviations, Symbols & Critiquing Requests and Reports
30 Radiology Administration, Organization & Leadership
30.1 Organizational Structure, Staffing & Licensing Requirements of a Radiology Facility 30.2 Radiology Department Management: Job Descriptions, Duties, Leadership Styles & Entrepreneurial Skills
26.2 Positron Emission Tomography (PET/CT) & Unsealed Radiation Source Safety
Key Takeaways Explain This Topic AI
Positron Emission Tomography (PET) is based on positron decay (b+) and positron-electron annihilation, which produces two 511 keV gamma photons emitted simultaneously at 180 degrees (+/- 0.25 deg) in opposite directions.
PET scanners utilize electronic coincidence detection across a 360-degree ring of scintillation crystals (LSO/LYSO), creating Lines of Response (LOR) without mechanical lead collimators, yielding up to 100-fold higher sensitivity than single-photon SPECT cameras.
Fluorine-18 Fluorodeoxyglucose (18F-FDG, T1/2 = 109.8 min) is a glucose analog that enters cells via GLUT transporters and undergoes metabolic trapping after phosphorylation by hexokinase into 18F-FDG-6-phosphate, accumulating in hypermetabolic malignant tumors.
Hybrid PET/CT scanners combine 3D functional PET metabolic data with multi-slice CT anatomical images, employing CT Hounsfield Units for rapid 511 keV CT Attenuation Correction (CT-AC) to shorten acquisition times and improve diagnostic accuracy.
Unsealed radiation safety protocols mandate tungsten syringe shielding for 511 keV PET photons, dose calibrator assay QC, GM counter area surveys, wipe testing (>2000 dpm/100 cm2 action limit), Decay-in-Storage (DIS for T1/2 < 90 days for 10 half-lives), and execution of the SWIMS spill protocol.
Last updated: August 2026
- 26.2 Positron Emission Tomography (PET/CT) & Unsealed Radiation Source Safety
- Positron Emission Tomography (PET) Physics & Annihilation Events
Positron Emission Tomography (PET) is a quantitative molecular imaging modality that detects pair production annihilation photons emitted following positron decay. PET provides unmatched functional evaluation of tissue metabolism, blood flow, and receptor density. +-------------------------------------------------------------------------+
- | POSITRON ANNIHILATION EVENT |
- +-------------------------------------------------------------------------+
- | 1. Proton-Rich Nucleus (e.g., F-18) decays via Beta-Plus (b+) |
- | |
- | 2. Emitted Positron (e+) travels short distance (Positron Range 0.5-2mm)|
- | losing kinetic energy in soft tissue. |
- | |
- | 3. Positron collides with a free Tissue Electron (e-). |
- | |
- | 4. ANNIHILATION: Mass of e+ and e- converted into pure energy (E=mc^2) |
- | |
- | 511 keV Gamma Photon <======== (180°) ========> 511 keV Gamma |
- | (Photons travel simultaneously in exactly opposite directions) |
- +-------------------------------------------------------------------------+
- 1. The Annihilation Event
Positron Emission ( β + \beta^+ β + Decay) : A proton-rich radionuclide (such as Fluorine-18, Carbon-11, Nitrogen-13, or Oxygen-15) undergoes β + \beta^+ β + decay, converting a nuclear proton into a neutron while emitting a positron ( e + \text{e}^+ e + ) and a neutrino ( ν \nu ν ).
Positron Range : The emitted positron travels a short distance ( 0.5 to 2.0 mm 0.5 \text{ to } 2.0 \text{ mm} 0.5 to 2.0 mm in tissue, known as the positron range ) while dissipating its kinetic energy through ionizations and collisions with tissue atoms.
Annihilation Reaction : Once the positron reaches thermal energy levels, it interacts with a free orbital electron ( e − \text{e}^- e − ) in surrounding soft tissue. The combined mass of both particles is completely annihilated and converted into energy according to Einstein's mass-energy equivalence equation ( E = m c 2 E = mc^2 E = m c 2 ).
Annihilation Photons : Annihilation produces two 511 keV 511 \ \text{keV} 511 keV gamma-ray photons that are emitted simultaneously ( 180 ∘ ± 0.25 ∘ 180^\circ \pm 0.25^\circ 18 0 ∘ ± 0.2 5 ∘ apart) in opposite directions along a straight line.
2. Electronic Coincidence Detection
Unlike single-photon gamma cameras that rely on lead collimators to restrict incoming photon angles, PET scanners utilize electronic coincidence detection . +-------------------------------------------------------------------------+
- | ELECTRONIC COINCIDENCE DETECTION |
- +-------------------------------------------------------------------------+
- | /--- Detector Crystal A ---\ |
- | / \ |
- | / Line of Response \ |
- | Detector Ring | <=========== (LOR) ===========> | Detector Ring |
- | | [ ANNIHILATION ] | |
- | \ / |
- | \ / |
- | \--- Detector Crystal B ---/ |
- | |
- | Coincidence Timing Circuit: Both 511 keV photons must strike A & B |
- | within Coincidence Time Window (3 - 12 nanoseconds) to record LOR. |
- +-------------------------------------------------------------------------+
Detector Ring Architecture : The PET gantry contains a complete 360 ∘ 360^\circ 36 0 ∘ circular array of thousands of small scintillation crystals (such as Lutetium Oxyorthosilicate [LSO] or Lutetium-Yttrium Oxyorthosilicate [LYSO] ) coupled to photomultiplier tubes or silicon photomultipliers (SiPMs).
Line of Response (LOR) : When two opposing 511 keV 511 \ \text{keV} 511 keV photons strike pair detectors on opposite sides of the ring within a strict coincidence timing window ( 3 to 12 nanoseconds 3 \text{ to } 12 \ \text{nanoseconds} 3 to 12 nanoseconds ) , the event is recorded as a valid annihilation occurring somewhere along the straight line connecting those two detectors ( Line of Response, LOR ).
Electronic Collimation : Because spatial geometry is determined by timing coincidence, PET requires no physical lead collimator septa . Removing lead collimators increases geometric detection efficiency and sensitivity by 100 × 100\times 100 × compared to conventional SPECT gamma cameras.
Coincidence Event Types :
True Coincidences : Both 511 keV 511 \ \text{keV} 511 keV photons from a single annihilation event reach opposing detectors unscattered within the timing window (desired diagnostic signal).
Scatter Coincidences : One or both photons undergo Compton scattering in patient tissue before detection, shifting the calculated LOR outside the true origin (degrades image contrast).
Random (Accidental) Coincidences : Two separate, unrelated annihilation events occur almost simultaneously, emitting photons that coincidentally hit opposing detectors within the timing window (adds noise background).
Time-of-Flight (TOF) PET : Advanced PET systems measure the infinitesimal time difference ( Δ t \Delta t Δ t , on the order of picoseconds) between the arrival of the two annihilation photons at opposing detectors. Measuring Δ t \Delta t Δ t pinpoints the exact position of the annihilation along the LOR, significantly increasing signal-to-noise ratio (SNR) and image quality, especially in obese patients.
- PET Radiopharmaceuticals & F-18 FDG Kinetics
- 1. Fluorine-18 Fluorodeoxyglucose ( 18 F-FDG ^{18}\text{F-FDG} 18 F-FDG )
18 F-FDG ^{18}\text{F-FDG} 18 F-FDG is the primary radiopharmaceutical utilized in clinical PET oncology, neurology, and cardiology, accounting for over 90 % 90\% 90% of all PET examinations.
Physical Properties of Fluorine-18 ( 18 F ^{18}\text{F} 18 F ) :
Physical half-life T 1 / 2 = 109.8 minutes ( ≈ 110 min ) T_{1/2} = 109.8 \ \text{minutes} \ (\approx 110 \ \text{min}) T 1/2 = 109.8 minutes ( ≈ 110 min ) .
Produced on site or regionally in a medical cyclotron by proton bombardment of Oxygen-18 enriched water via the nuclear reaction: 18 O ( p , n ) 18 F ^{18}\text{O}(p,n)^{18}\text{F} 18 O ( p , n ) 18 F . +-------------------------------------------------------------------------+
- | 18F-FDG METABOLIC TRAPPING MECHANISM |
- +-------------------------------------------------------------------------+
- | Extracellular Fluid Intracellular Space |
- | |
- | [ 18F-FDG Molecule ] -- (GLUT-1 / GLUT-4) --> [ 18F-FDG in Cytosol ] |
- | | |
- | Hexokinase |
- | | |
- | v |
- | [ 18F-FDG-6-Phosphate ] |
- | | |
- | * METABOLIC TRAPPING * |
- | (Cannot enter Glycolysis; |
- | Cannot exit Cell Membrane)|
- +-------------------------------------------------------------------------+
Mechanism of Accumulation & Metabolic Trapping :
18 F-FDG ^{18}\text{F-FDG} 18 F-FDG is a glucose analog in which a hydroxyl group ( -OH \text{-OH} -OH ) at the C-2 position of the glucose molecule is replaced by radioactive Fluorine-18.
18 F-FDG ^{18}\text{F-FDG} 18 F-FDG is transported across cell membranes into the cytoplasm via glucose transporter proteins ( GLUT-1 and GLUT-4 ), which are overexpressed on malignant cancer cells.
Inside the cell cytoplasm, the enzyme hexokinase phosphorylates 18 F-FDG ^{18}\text{F-FDG} 18 F-FDG into 18 F-FDG-6-Phosphate ^{18}\text{F-FDG-6-Phosphate} 18 F-FDG-6-Phosphate .
Because 18 F-FDG-6-phosphate ^{18}\text{F-FDG-6-phosphate} 18 F-FDG-6-phosphate lacks a 2'-hydroxyl group, it cannot be recognized by glucose-6-phosphate isomerase and cannot undergo further glycolysis . Furthermore, because it is negatively charged, it cannot diffuse backward out of the cell membrane.
This phenomenon—known as metabolic trapping —causes 18 F-FDG-6-phosphate ^{18}\text{F-FDG-6-phosphate} 18 F-FDG-6-phosphate to accumulate inside hypermetabolic cells in direct proportion to their glucose metabolic rate ( Warburg Effect in cancer cells).
Normal Physiological Biodistribution :
Intense uptake: Brain cortex (high baseline glucose metabolism), myocardium.
Moderate uptake: Liver, spleen, tonsils, GI tract, bone marrow.
Excretion: Excreted renal system (intense activity in kidneys, ureters, and urinary bladder).
Clinical preparation: Patient must fast for 4 to 6 hours 4 \text{ to } 6 \ \text{hours} 4 to 6 hours prior to 18 F-FDG ^{18}\text{F-FDG} 18 F-FDG injection to minimize serum glucose competition. Serum glucose must be verified ( < 150 to 200 mg/dL <150 \text{ to } 200 \ \text{mg/dL} < 150 to 200 mg/dL ) prior to administration.
2. Other Key PET Radiopharmaceuticals
18 F-NaF ^{18}\text{F-NaF} 18 F-NaF (Sodium Fluoride) : High-resolution PET bone scanning agent; incorporates into hydroxyapatite.
18 F-PSMA ^{18}\text{F-PSMA} 18 F-PSMA / 68 Ga-PSMA ^{68}\text{Ga-PSMA} 68 Ga-PSMA : Prostate-Specific Membrane Antigen ligands for staging and recurrent prostate carcinoma.
68 Ga-DOTATATE ^{68}\text{Ga-DOTATATE} 68 Ga-DOTATATE / 68 Ga-DOTATOC ^{68}\text{Ga-DOTATOC} 68 Ga-DOTATOC : Somatostatin receptor analogs for neuroendocrine tumor (NET) evaluation.
11 C-Choline ^{11}\text{C-Choline} 11 C-Choline : T 1 / 2 = 20.4 min T_{1/2} = 20.4 \ \text{min} T 1/2 = 20.4 min ; cell membrane lipid synthesis tracer.
13 N-Ammonia ^{13}\text{N-Ammonia} 13 N-Ammonia : T 1 / 2 = 9.96 min T_{1/2} = 9.96 \ \text{min} T 1/2 = 9.96 min ; quantitative myocardial blood flow perfusion tracer.
15 O-Water ^{15}\text{O-Water} 15 O-Water : T 1 / 2 = 122 seconds T_{1/2} = 122 \ \text{seconds} T 1/2 = 122 seconds ; gold-standard blood flow tracer.
Hybrid PET/CT Imaging & Attenuation Correction
Modern PET scanners are manufactured exclusively as hybrid PET/CT systems, combining a 3D PET detector ring and a multi-slice helical CT scanner aligned co-axially.
Advantages of Hybrid PET/CT
Anatomical Coregistration : Overlays precise anatomical CT structures onto functional PET metabolic activity, allowing accurate localization of small malignant tumor nodes, distinguishing physiological muscle/bowel uptake from true pathology.
CT-Based Attenuation Correction (CT-AC) : 511 keV 511 \ \text{keV} 511 keV photons exiting deep abdominal tissues are attenuated by soft tissue and bone. In standalone PET, attenuation correction required external Germanium-68 ( 68 Ge ^{68}\text{Ge} 68 Ge ) rod source transmission scans taking 15 to 20 minutes 15 \text{ to } 20 \ \text{minutes} 15 to 20 minutes per bed position. In PET/CT, a low-dose CT scan converts Hounsfield Units into linear attenuation coefficients ( μ \mu μ ) at 511 keV 511 \ \text{keV} 511 keV , performing attenuation correction in less than 1 minute and reducing total scan time from 45 minutes to 15 minutes.
Modality Comparison: PET vs. SPECT
Parameter / Feature Single Photon Emission Computed Tomography (SPECT) Positron Emission Tomography (PET)
Emitted Radiation Single gamma photon (e.g., 140 keV 140 \ \text{keV} 140 keV for 99 m Tc ^{99m}\text{Tc} 99 m Tc ) Two coincident 511 keV 511 \ \text{keV} 511 keV annihilation photons at 180 ∘ 180^\circ 18 0 ∘
Collimation Physical lead/tungsten collimators (Parallel, Pinhole) Electronic coincidence detection (No physical collimator)
Detector Material Sodium Iodide Thallium-doped NaI(Tl) \text{NaI(Tl)} NaI(Tl) crystal Lutetium Oxyorthosilicate (LSO) or LYSO crystals
Spatial Resolution 8 to 12 mm 8 \text{ to } 12 \ \text{mm} 8 to 12 mm cross-sectional resolution 3 to 5 mm 3 \text{ to } 5 \ \text{mm} 3 to 5 mm cross-sectional resolution
Detection Sensitivity Low ( < 0.1 % <0.1\% < 0.1% of emitted photons detected) High ( 100 × 100\times 100 × higher sensitivity than SPECT)
Primary Radionuclides 99 m Tc , 131 I , 123 I , 201 Tl , 67 Ga , 111 In ^{99m}\text{Tc}, ^{131}\text{I}, ^{123}\text{I}, ^{201}\text{Tl}, ^{67}\text{Ga}, ^{111}\text{In} 99 m Tc , 131 I , 123 I , 201 Tl , 67 Ga , 111 In 18 F , 11 C , 13 N , 15 O , 68 Ga , 82 Rb ^{18}\text{F}, ^{11}\text{C}, ^{13}\text{N}, ^{15}\text{O}, ^{68}\text{Ga}, ^{82}\text{Rb} 18 F , 11 C , 13 N , 15 O , 68 Ga , 82 Rb
Primary Application Bone scans, cardiac perfusion, renal function Oncology staging, glucose metabolism, neuro-PET
Radiation Safety for Unsealed Sources
Unlike sealed radiation sources (encapsulated radioactive seeds or external beams), unsealed radioactive sources (liquid solutions, gases, aerosols) present both external radiation hazards and severe internal contamination hazards (via ingestion, inhalation, skin absorption, or accidental injection). +-------------------------------------------------------------------------+
- | HOT LAB RADIATION PROTECTION TOOLKIT |
- +-------------------------------------------------------------------------+
- | [ Tungsten Syringe Shield ] -> Reduces finger hand dose >90% (PET/Tc) |
- | [ Lead L-Block Shield ] -> Leaded glass window protects face/body |
- | [ Dose Calibrator ] -> Gas ionization chamber assays mCi/MBq |
- | [ GM Counter Survey Meter ] -> Detects low-level spills (mR/h or cpm) |
- | [ NaI Well Counter ] -> Assays removable wipe tests (dpm) |
- | [ DIS Storage Room ] -> Stores waste T1/2 < 90d for 10 half-lives|
- +-------------------------------------------------------------------------+
- 1. Hot Lab Handling & Dose Preparation
L-Block Shield : Handling radiopharmaceuticals must take place behind a lead L-block shield equipped with a 2 to 4 inch 2 \text{ to } 4 \ \text{inch} 2 to 4 inch thick lead glass window to shield the technologist's torso and eyes.
Syringe Shields : High-density tungsten or leaded glass syringe shields must be used during dose draw and patient administration. For 511 keV 511 \ \text{keV} 511 keV PET photons, high-density tungsten syringe shields ( 6 to 9 mm 6 \text{ to } 9 \ \text{mm} 6 to 9 mm thick) reduce extremity hand dose by 90 % to 99 % 90\% \text{ to } 99\% 90% to 99% .
Dose Calibrator (Ionization Chamber) : A gas-filled well-type ionization chamber used to assay the absolute activity of radiopharmaceutical doses in millicuries ( mCi \text{mCi} mCi ) or Megabecquerels ( MBq \text{MBq} MBq ) before patient injection.
Mandatory Quality Control Tests :
Constancy : Tested daily using a long-lived sealed source (e.g., Cesium-137 or Cobalt-57); must be within ± 10 % \pm 10\% ± 10% of expected value.
Linearity : Tested quarterly over the entire decay range from maximum patient dose down to 30 μ Ci 30 \ \mu\text{Ci} 30 μ Ci ; verifies accurate reading across decay levels.
Accuracy : Tested annually using NIST-traceable standards (e.g., Co-57, Ba-133, Cs-137); must be within ± 10 % \pm 10\% ± 10% .
Geometry : Tested at installation and after repair ; evaluates reading changes caused by varying sample volumes ( 1 mL to 10 mL 1 \ \text{mL} \text{ to } 10 \ \text{mL} 1 mL to 10 mL ) or container configurations (syringe vs vial).
2. Survey Instruments & Wipe Testing
Geiger-Müller (GM) Counter : High-sensitivity gas-filled detector used to perform routine daily end-of-day radiation surveys of work surfaces and detect low-level radioactive contamination (measures in mR/hr \text{mR/hr} mR/hr or counts per minute, cpm \text{cpm} cpm ).
Cutie Pie (Ionization Chamber Survey Meter) : Used for measuring high exposure rates (in R/hr \text{R/hr} R/hr ) around patients receiving therapeutic doses (e.g., Iodine-131 therapy patients) without experiencing instrument saturation.
Wipe Test (Smear Test) : Mandatory weekly monitoring for removable radioactive contamination . An absorbent filter paper is wiped over a 100 cm 2 100 \ \text{cm}^2 100 cm 2 surface area and counted in a Sodium Iodide (NaI) Well Counter.
Action Threshold : Contamination exceeding 2000 dpm / 100 cm 2 2000 \ \text{dpm} / 100 \ \text{cm}^2 2000 dpm /100 cm 2 (disintegrations per minute) for beta/gamma emitters requires immediate decontamination and re-surveying.
3. Radioactive Waste Disposal & Decay-in-Storage (DIS)
Decay-in-Storage (DIS) : Applicable to unsealed radionuclides with a physical half-life of less than 90 days ( T 1 / 2 < 90 days T_{1/2} < 90 \ \text{days} T 1/2 < 90 days , e.g., 99 m Tc , 18 F , 123 I , 131 I , 111 In ^{99m}\text{Tc}, ^{18}\text{F}, ^{123}\text{I}, ^{131}\text{I}, ^{111}\text{In} 99 m Tc , 18 F , 123 I , 131 I , 111 In ).
Waste is segregated in lead-lined decay storage containers for a minimum of 10 physical half-lives .
After 10 half-lives (when activity decays to < 0.1 % <0.1\% < 0.1% of initial value), waste radiation levels are surveyed with a GM counter in a low-background area. If radiation equals background levels, radioactive hazard labels are removed or defaced, and waste is disposed of as non-radioactive medical waste.
4. Emergency Radioactive Spill Protocol (SWIMS)
When an unsealed radioactive spill occurs, the technologist must immediately execute the SWIMS emergency protocol:
S - Stop the Spill : Upright the spilled container immediately using tongs or gloved hands to prevent further liquid spread.
W - Warn Others : Immediately notify all personnel in the area of the spill and instruct non-essential persons to leave the room.
I - Isolate the Area : Close all doors, lock access, and post radioactive hazard warning signs to prevent inadvertent entry.
M - Minimize Exposure & Contamination : Wear protective clothing (double gloves, lab coat, disposable shoe covers). Avoid stepping in liquid.
S - Survey & Decontaminate : Clean up liquid using absorbent paper starting from the outer perimeter working inward toward the center. Monitor personnel, clothing, and skin with a GM counter. Report the spill immediately to the Radiation Safety Officer (RSO) .
Unsealed Source Safety & Monitoring Summary
Instrument / Protocol Operating Physics / Method Frequency Primary Purpose & Clinical Action Threshold
Tungsten Syringe Shield High-Z tungsten absorption ( 6 − 9 mm 6-9 \ \text{mm} 6 − 9 mm ) Every Injection Reduces technologist hand dose by > 90 % >90\% > 90% during 511 keV 511 \ \text{keV} 511 keV PET injection.
Dose Calibrator QC Well ionization chamber volume assay Daily (Constancy), Quarterly (Linearity), Annually (Accuracy) Verifies patient dose assay within ± 10 % \pm 10\% ± 10% of true activity prior to injection.
GM Counter Survey Gas avalanche ionization detection Daily (end of shift) Area survey of hot lab surfaces; detects low-level ambient exposure ( mR/hr \,\text{mR/hr}\, mR/hr ).
Wipe Test (Smear) Filter paper wipe counted in NaI Well Counter Weekly Measures removable contamination; action threshold > 2000 dpm / 100 cm 2 >2000 \ \text{dpm} / 100 \ \text{cm}^2 > 2000 dpm /100 cm 2 .
Decay-in-Storage (DIS) Decay storage for T 1 / 2 < 90 days T_{1/2} < 90 \ \text{days} T 1/2 < 90 days Continuous Retains waste for ≥ 10 half-lives \ge 10 \ \text{half-lives} ≥ 10 half-lives ; dispose as normal waste once at background.
SWIMS Spill Protocol Emergency containment algorithm Immediate upon spill S top, W arn, I solate, M inimize exposure, S urvey & clean perimeter inward.